Baxter settles FDA warning letter over problems at 3 overseas plants

10/21/2011 | Reuters

Baxter International has settled an FDA warning letter it received in January over concerns that it violated good manufacturing practice standards and failed to file post-market reports at its two facilities in Puerto Rico. The company also resolved safety issues related to peritoneal dialysis solutions manufactured at its facility in Ireland.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN